Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank36
3Y CAGR-20.6%
5Y CAGR-16.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-20.6%/yr
vs -16.7%/yr prior
5Y CAGR
-16.2%/yr
Recent deceleration
Acceleration
-3.9pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$58.00M-
2024$0.00-
2023$0.00-100.0%
2022$115.99M-
2021$0.00-100.0%
2020$140.00M-
2019$0.00-100.0%
2018$241.29M+3.5%
2017$233.12M+34.5%
2016$173.28M-